202 related articles for article (PubMed ID: 29088933)
1. Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
Goes FS; Sawa A
Am J Psychiatry; 2017 Nov; 174(11):1027-1029. PubMed ID: 29088933
[No Abstract] [Full Text] [Related]
2. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
[TBL] [Abstract][Full Text] [Related]
3. 22q11.2 Deletion Syndrome: Characterization of Psychosis Spectrum and Future Directions.
Radoeva PD
Biol Psychiatry; 2017 Jul; 82(1):e5-e7. PubMed ID: 28619254
[No Abstract] [Full Text] [Related]
4. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
[TBL] [Abstract][Full Text] [Related]
5. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
[TBL] [Abstract][Full Text] [Related]
6. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
Carandang CG; Scholten MC
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559
[TBL] [Abstract][Full Text] [Related]
7. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
Jolin EM; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762
[TBL] [Abstract][Full Text] [Related]
8. Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome.
Sieberer M; Haltenhof H; Haubitz B; Pabst B; Miller K; Garlipp P
Eur Psychiatry; 2005 Dec; 20(8):567-9. PubMed ID: 15967641
[TBL] [Abstract][Full Text] [Related]
9. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
10. [Microdeletion of 22q11, DiGeorge and velocardiofacial syndrome].
Hjalgrim H; Hahnemann JM; Timshel S; Brøndum-Nielsen K
Ugeskr Laeger; 2000 Jul; 162(31):4169-70. PubMed ID: 10962926
[No Abstract] [Full Text] [Related]
11. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
[TBL] [Abstract][Full Text] [Related]
12. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
Schwinger E; Devriendt K; Rauch A; Philip N
Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
[No Abstract] [Full Text] [Related]
14. Deletion 22q11: spectrum of associated disorders.
Hay BN
Semin Pediatr Neurol; 2007 Sep; 14(3):136-9. PubMed ID: 17980310
[TBL] [Abstract][Full Text] [Related]
15. Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.
Gur RE; Roalf DR; Alexander-Bloch A; McDonald-McGinn DM; Gur RC
Curr Opin Genet Dev; 2021 Jun; 68():35-40. PubMed ID: 33571729
[TBL] [Abstract][Full Text] [Related]
16. DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome.
Sullivan KE
Adv Exp Med Biol; 2007; 601():37-49. PubMed ID: 17712990
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
Sullivan KE
Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
[TBL] [Abstract][Full Text] [Related]
18. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
19. Psychosis, electrolyte imbalance, and velocardiofacial syndrome.
Thomas ZS
Psychosomatics; 2003; 44(4):348-50. PubMed ID: 12832604
[No Abstract] [Full Text] [Related]
20. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
Wulfsberg EA
Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
